Crinetics Pharmaceuticals Inc.获得FDA孤儿药资格认定,Atumelnant用于治疗先天性肾上腺增生症(CAH)
Crinetics Pharmaceuticals Inc.获得FDA孤儿药资格认定,Atumelnant用于治疗先天性肾上腺增生症(CAH)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.